These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7778073)

  • 81. Quantitation of antibody-secreting cells in the blood after vaccination with Haemophilus influenzae type b conjugate vaccine.
    Barington T; Heilmann C; Andersen V
    Scand J Immunol; 1990 Apr; 31(4):515-22. PubMed ID: 2185534
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Anti-Haemophilus influenzae b (Hib) natural immunity in children in Burkina Faso].
    Tall F; Elola A; Vincent-Ballereau F; Prazuck T
    Arch Pediatr; 1994 Feb; 1(2):143-6. PubMed ID: 7987440
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Severe apnoeas following immunisation in premature infants.
    Slack MH; Schapira D
    Arch Dis Child Fetal Neonatal Ed; 1999 Jul; 81(1):F67-8. PubMed ID: 10375367
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Clustering of cases of insulin dependent diabetes (IDDM) occurring three years after hemophilus influenza B (HiB) immunization support causal relationship between immunization and IDDM.
    Classen JB; Classen DC
    Autoimmunity; 2002 Jul; 35(4):247-53. PubMed ID: 12482192
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Comparison of nonhuman primate antibodies against Haemophilus influenzae type b polysaccharide with human antibodies in oligoclonality and in vivo protective potency.
    Kim KH; Park MK; Peeters CC; Poolman JT; Shearer MH; Kennedy RC; Nahm MH
    Infect Immun; 1994 Jun; 62(6):2426-31. PubMed ID: 8188367
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Experience with anti-Haemophilus influenzae type B vaccination in children under 2 years of age].
    Galli MG; Podda A; Costantino P; Viti A; Aiello L; Ceratti F; Consonni M
    Ann Ig; 1993; 5(2):91-5. PubMed ID: 7510979
    [No Abstract]   [Full Text] [Related]  

  • 87. Underimmunization in Chicago children who dropped out of WIC.
    Cortese MM; Diaz PS; Samala U; Mennone JZ; Mihalek EF; Matuck MJ; Johnson-Partlow T; Dicker RC; Paul WS
    Am J Prev Med; 2004 Jan; 26(1):29-33. PubMed ID: 14700709
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b.
    Smith DH; Peter G; Ingram DL; Harding AL; Anderson P
    Pediatrics; 1973 Nov; 52(5):637-44. PubMed ID: 4542777
    [No Abstract]   [Full Text] [Related]  

  • 89. Haemophilus influenzae b polysaccharide vaccine. Physician acceptance and use of a new vaccine.
    Cochi SL; Fleming DW; Hull HF; Preblud SR; Orenstein WA
    Am J Dis Child; 1986 Dec; 140(12):1226-30. PubMed ID: 3490784
    [TBL] [Abstract][Full Text] [Related]  

  • 90. b-CAPSA I Haemophilus influenzae, type b, capsular polysaccharide vaccine safety.
    Black SB; Shinefield HR
    Pediatrics; 1987 Mar; 79(3):321-5. PubMed ID: 3822630
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Association of placental transfer of anti-Haemophilus influenzae type b polysaccharide antibodies with their V regions.
    Park MK; Englund JA; Glezen WP; Siber GR; Nahm MH
    Vaccine; 1996 Sep; 14(13):1219-22. PubMed ID: 8961508
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [The results of the registration clinical trials of the Act-Hib vaccine manufactured by the firm of Pasteur Mérieux Connaught, France].
    Gorbunov MA; Pavlova LI; Chuprinina RP; Nemirovskaia TI
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (2):45-8. PubMed ID: 10356736
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Clarifying HIB schedules.
    John R
    MCN Am J Matern Child Nurs; 1992; 17(4):180. PubMed ID: 1635426
    [No Abstract]   [Full Text] [Related]  

  • 94. Cost-benefit analysis of general vaccination against Haemophilus influenzae type b in Sweden.
    Trollfors B
    Scand J Infect Dis; 1994; 26(5):611-4. PubMed ID: 7855559
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A model to estimate the probability of hepatitis B- and Haemophilus influenzae type b-vaccine uptake into national vaccination programs.
    Miller MA; Flanders WD
    Vaccine; 2000 Apr; 18(21):2223-30. PubMed ID: 10717341
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Haemophilus influenzae type b polysaccharide vaccine.
    CMAJ; 1987 Sep; 137(5):420-1. PubMed ID: 3497704
    [No Abstract]   [Full Text] [Related]  

  • 97. A retrospective study on the quality of Haemophilus influenzae type b vaccines used in the UK between 1996 and 2004.
    Bolgiano B; Mawas F; Burkin K; Crane DT; Saydam M; Rigsby P; Corbel MJ
    Hum Vaccin; 2007; 3(5):176-82. PubMed ID: 17786035
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Survey of parents' attitudes to the recommended Haemophilus influenzae type b vaccine program.
    Shawn DH; Gold R
    CMAJ; 1987 May; 136(10):1038-40. PubMed ID: 3494496
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The position statement on injection technique.
    Diggle L; Deeks J
    Arch Dis Child; 2002 Nov; 87(5):452-3. PubMed ID: 12390937
    [No Abstract]   [Full Text] [Related]  

  • 100. [Papular acrodermatitis without infection].
    Redondo Granado MJ; Galeazzi Martínez V; Alvarez Rabanal M; Zlatanova Gueorgieva A
    An Pediatr (Barc); 2007 Oct; 67(4):405-6. PubMed ID: 17949656
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.